Drug interactions
Bumetanide + Tiotropium-olodaterol
Severity: Moderate
Bumetanide and Tiotropium-olodaterol: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Loop diuretics cause potassium loss, and beta2 agonists such as olodaterol can shift potassium into cells. Together they can produce clinically relevant hypokalemia, which raises the risk of arrhythmia, especially in patients with heart disease or on digoxin.
What this interaction means in plain words
Bumetanide and Tiotropium-olodaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Bumetanide belongs to Cardiovascular; Tiotropium-olodaterol belongs to Respiratory.
Why it happens
Additive lowering of serum potassium through renal loss (bumetanide) and intracellular shift (beta2 stimulation).
What to do
Check serum potassium at baseline and periodically during combined use. Replace potassium and magnesium as needed, particularly in patients with cardiac disease or high doses.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Bumetanide and Tiotropium-olodaterol, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Tiotropium-olodaterol
Other interactions of Bumetanide
Frequently asked questions
Can I take Bumetanide with Tiotropium-olodaterol?
MediHelp rates the interaction as moderate. Bumetanide and Tiotropium-olodaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Loop diuretics cause potassium loss, and beta2 agonists such as olodaterol can shift potassium into cells. Together they can produce clinically relevant hypokalemia, which raises the risk of arrhythmia, especially in patients with heart disease or on digoxin.
How serious is the interaction between Bumetanide and Tiotropium-olodaterol?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check serum potassium at baseline and periodically during combined use. Replace potassium and magnesium as needed, particularly in patients with cardiac disease or high doses.
What other medicines interact with Tiotropium-olodaterol?
MediHelp also lists interactions of Tiotropium-olodaterol with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Tiotropium-olodaterol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
